Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ME2 | P23368 | 3/20 | 0.52 |
| ▸ | ME1 | P48163 | 3/20 | 0.52 |
| ▸ | ME3 | Q16798 | 3/20 | 0.52 |
| ▸ | KDM1A | O60341 | 2/20 | 0.48 |
| ▸ | DRD3 | P35462 | 8/20 | 0.47 |
| ▸ | HTR2A | P28223 | 2/20 | 0.46 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD5 | P21918 | 1/20 | 0.46 |
| ▸ | HRH2 | P25021 | 1/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2157259 | 0.91 | ME2 (0.53) | ME2ME1ME3DRD3HTR2A | |
| SCHEMBL2157428 | 0.91 | HTR2A (0.47) | ME2ME1ME3KDM1ADRD3 | |
| SCHEMBL2157567 | 0.90 | ME2 (0.58) | ME2ME1ME3KDM1ADRD3 | |
| SCHEMBL2157298 | 0.88 | DRD3 (0.45) | ME2ME1ME3KDM1ADRD3 | |
| SCHEMBL2157386 | 0.88 | HTR2A (0.47) | ME2ME1ME3KDM1ADRD3 | |
| SCHEMBL2157673 | 0.86 | DRD3 (0.51) | KDM1ADRD3HTR2ACACNA1FDRD4 | |
| SCHEMBL2157319 | 0.86 | DRD3 (0.48) | KDM1ADRD3HTR2ACACNA1FHTR1A | |
| SCHEMBL2157373 | 0.85 | CACNA1F (0.54) | ME2ME1ME3KDM1ADRD3 | |
| SCHEMBL2158134 | 0.85 | DRD3 (0.47) | ME2ME1ME3KDM1ADRD3 | |
| SCHEMBL2157384 | 0.84 | CACNA1F (0.46) | KDM1ADRD3HTR2ACACNA1FHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8183374-B2 | Piperidine and piperazine derivatives | M'S SCIENCE CORPORATION (JP) | 2012-05-22 | — | — | US | disclosed |
| EP-2340835-A1 | Piperidine and piperazine derivatives | M's Science Corporation (JP) | 2011-07-06 | — | — | EP | disclosed |
| EP-1976525-B1 | PIPERIDINE AND PIPERAZINE DERIVATIVES | MS SCIENCE CORP (JP) | 2010-11-03 | — | — | EP | disclosed |
| US-20100137334-A1 | Piperidine and Piperazine Derivatives | SUN CONNIE L | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137334-A1 | Piperidine and Piperazine Derivatives | SIGMAR1, OPRM1, OPRD1 | ME2 2253/4885ME1 2741/4885ME3 2357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.